TPIV


Why TapImmune (TPIV) Stock Is Skyrocketing… Again

Shares of the immuno-oncology company soared on news it was raising capital.

Exclusive Interview With TapImmune, Inc. (TPIV) President And COO Dr. John Bonfiglio

If you’re a biotech investor who has not yet heard of TapImmune, Inc. (NASDAQ: TPIV), this clinical-stage immune-oncology company is charging its way …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts